Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

RETACRIT™ (epoetin alfa-epbx)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

RETACRIT™ Quick Finder

  • Pfizer enCompass™
  • Need Information on Pfizer’s Patient Assistance Programs?
  • Have a Question about Pfizer Clinical Trials?
  • Need to report an Adverse Event, Side Effect, or Product Quality Concern?
Download Prescribing Information
Show All Hide All

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the...
Read more
Did you find an answer to your question? Yes No

WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE

...

Read more
Did you find an answer to your question? Yes No

1 INDICATIONS AND USAGE

1.1 Anemia Due to Chronic Kidney Disease

RETACRIT is indicated for the treatment of anemia due to chronic kidney disease (CKD), including...

Read more
Did you find an answer to your question? Yes No

2 DOSAGE AND ADMINISTRATION

2.1 Important Dosing Information

Evaluation of Iron Stores and...

Read more
Did you find an answer to your question? Yes No

3 DOSAGE FORMS AND STRENGTHS

Injection:

•
2,000 Units/mL, 3,000 Units/mL, 4,000 Units/mL, 10,000 Units/mL, and 40,000 Units/mL of RETACRIT as a clear and...
Read more
Did you find an answer to your question? Yes No

5 WARNINGS AND PRECAUTIONS

5.1 Increased Mortality, Myocardial Infarction, Stroke, and Thromboembolism

•
In controlled clinical trials of patients with CKD comparing...
Read more
Did you find an answer to your question? Yes No

6 ADVERSE REACTIONS

The following serious adverse reactions are discussed in greater detail in other sections of the label:

•
Increased Mortality, Myocardial Infarction, Stroke, and Thromboembolism...
Read more
Did you find an answer to your question? Yes No

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Risk Summary

RETACRIT from multiple...

Read more
Did you find an answer to your question? Yes No

10 OVERDOSAGE

RETACRIT overdosage can cause hemoglobin levels above the desired level, which should be managed with discontinuation or reduction of RETACRIT dosage and/or with phlebotomy, as clinically indicated...

Read more
Did you find an answer to your question? Yes No

11 DESCRIPTION

Epoetin alfa-epbx is an erythropoiesis-stimulating agent. Epoetin alfa-epbx is a 165-amino acid glycoprotein manufactured by recombinant DNA technology. It has a molecular weight of approximately 30,400...

Read more
Did you find an answer to your question? Yes No

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

Epoetin alfa products stimulate erythropoiesis by the same mechanism as endogenous erythropoietin.

...
Read more
Did you find an answer to your question? Yes No

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

The carcinogenic potential of epoetin alfa products has not been evaluated.

...

Read more
Did you find an answer to your question? Yes No

14 CLINICAL STUDIES

14.1 Patients with Chronic Kidney Disease

Adult Patients on Dialysis...

Read more
Did you find an answer to your question? Yes No

16 HOW SUPPLIED/STORAGE AND HANDLING

RETACRIT (epoetin alfa-epbx) injection is a sterile, clear, and colorless solution in single-dose and multiple-dose vials available as:

...
Read more
Did you find an answer to your question? Yes No
...

This Medication Guide has been approved by the U.S. Food and Drug Administration.

Read more
Did you find an answer to your question? Yes No

Instructions for Use

RETACRIT® (Ret-uh-krit)
(epoetin alfa-epbx)

Use these Instructions for Use if you or your caregiver has been...

Read more
Did you find an answer to your question? Yes No

This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.

...
Read more
Did you find an answer to your question? Yes No
Show All Hide All
Did you find an answer to your question? Yes No

Resources

Pfizer enCompass™
Pfizer enCompass™ is a resource available to patients on RETACRIT therapy. Support includes assistance for eligible uninsured and insured patients who cannot afford their out-of-pocket costs. To learn more, call Pfizer enCompass to talk to an Access Counselor at (844) 722-6672 or visit the Pfizer enCompass website.
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

To interact with the Medical Information Digital Assistant click here.

Call (800) 438-1985

Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985

Report Adverse Event
Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.